Henk-Jan Boersema

105 Residual work capacity and (in)ability to work fulltime among applicants with cancer 18. Paraponaris A, Teyssier LS, Ventelou B. Job tenure and self-reported workplace discrimination for cancer survivors 2 years after diagnosis: does employment legislation matter? Health Policy. 2010;98(2-3):144-55. 19. Luker K, Campbell M, Amir Z, Davies L. A UK survey of the impact of cancer on employment. Occup Med (Lond). 2013;63(7):494-500. 20. Torp S, Nielsen RA, Fossa SD, Gudbergsson SB, Dahl AA. Change in employment status of 5-year cancer survivors. Eur J Public Health. 2013;23(1):116-22. 21. Marino P, Teyssier LS, Malavolti L, Le Corroller-Soriano AG. Sex differences in the return-to-work process of cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31(10):1277-84. 22. De Boer A, Verbeek J, Spelten E, Uitterhoeve A, Ansink A, De Reijke T, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342-7. 23. Roelen CA, Koopmans PC, Groothoff JW, van der Klink JJ, Bultmann U. Return to work after cancer diagnosed in 2002, 2005 and 2008. J Occup Rehabil. 2011;21(3):335-41. 24. van Muijen P, Duijts SF, Bonefaas-Groenewoud K, van der Beek AJ, Anema JR. Factors associated with work disability in employed cancer survivors at 24-month sick leave. BMC Cancer. 2014;14:236. 25. Cronin S, Curran J, Iantorno J, Murphy K, Shaw L, Boutcher N, et al. Work capacity assessment and return to work: a scoping review. Work. 2013;44(1):37-55. 26. Sengers JH, Abma FI, Ståhl C, Brouwer S. Work capacity assessments and efforts to achieve a job match for claimants in a social security setting: an international inventory. Disabil Rehabil. 2020:1-10. 27. Boersema H-J, Cornelius B, de Boer WE, van der Klink JJ, Brouwer S. The assessment of work endurance in disability evaluations across European countries. PloS One. 2018;13(9):e0202012. 28. Boersema H-J, Hoekstra T, Abma F, Brouwer S. Inability to work fulltime, prevalence and associated factors among applicants for work disability benefit. J Occup Rehabil. 2021;31(4):796-806. 29. RIVM (National Institute of Public Health and th Environment). Overleving Kanker (Survival Cancer). 2021. Available from: https://www.volksgezondheidenzorg.info/ onderwerp/kanker/cijfers-context/sterfte-en-overleving#node-overleving-kanker. 30. Netherlands Gov. Wet werk en inkomen naar arbeidsvermogen (Work and Income Act). 2005 Dec 7, 2020. Available from: https://wetten.overheid.nl/ BWBR0019057/2020-03-19. 31. Netherlands Gov. Schattingsbesluit Arbeidsongeschiktheidswetten (Disability Assessment Rule). 2021. Available from: https://wetten.overheid.nl/ BWBR0011478/2021-01-01. 32. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-2015-WHO. 2015. Available from: https://icd.who.int/browse10/2015/en. 33. UWV Sociaal medische Zaken. Duurbelastbaarheid in arbeid (Endurance capacity in work). 2015. Available from: https://nvab-online.nl/sites/default/files/bestandenwebpaginas/Standaard%20Duurbelastbaarheid%20in%20Arbeid.pdf. 34. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577-92. 5

RkJQdWJsaXNoZXIy MTk4NDMw